← Back to Clinical Trials
Recruiting NCT06782906

NCT06782906 Effect of Increased Physical Activity and Stopping Evening Snacking in Metabolic Health in Youth With Prediabetes

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06782906
Status Recruiting
Phase
Sponsor Baylor College of Medicine
Condition Prediabetes
Study Type INTERVENTIONAL
Enrollment 80 participants
Start Date 2025-05-13
Primary Completion 2029-09

Eligibility & Interventions

Sex All sexes
Min Age 12 Years
Max Age 18 Years
Study Type INTERVENTIONAL
Interventions
≥10,000 daily steps (≥5 days/week) and stopping evening snacking

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 80 participants in total. It began in 2025-05-13 with a primary completion date of 2029-09.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Non-healthy eating habits and a lack of exercise contribute to prediabetes and type 2 diabetes (T2D). Evening snacking is linked to abnormal weight gain in adults and healthy adolescents. Most adolescents do not get enough exercise. This study aims to look at the benefits of more exercise and stopping evening snacking in youth with prediabetes. The study lasts 8 weeks, and participants will be randomly assigned to either an intervention group or a standard of care group.

Eligibility Criteria

Inclusion Criteria: 1. 12-18 years of age 2. Having a diagnosis of prediabetes 3. Engaging in frequent evening snacking 4. Inadequate physical activity Exclusion Criteria: 1. Diagnosis of diabetes 2. Significant history of chronic disease 3. Evidence of significant liver or kidney disease; 4. Any hormone replacement therapy; and 5. Pregnancy.

Contact & Investigator

Central Contact

Mustafa Tosur, MD

✉ mustafa.tosur@bcm.edu

📞 832-822-3780

Principal Investigator

Mustafa Tosur, MD

PRINCIPAL INVESTIGATOR

Baylor College of Medicine

Frequently Asked Questions

Who can join the NCT06782906 clinical trial?

This trial is open to participants of all sexes, aged 12 Years or older, up to 18 Years, studying Prediabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06782906 currently recruiting?

Yes, NCT06782906 is actively recruiting participants. Contact the research team at mustafa.tosur@bcm.edu for enrollment information.

Where is the NCT06782906 trial being conducted?

This trial is being conducted at Houston, United States.

Who is sponsoring the NCT06782906 clinical trial?

NCT06782906 is sponsored by Baylor College of Medicine. The principal investigator is Mustafa Tosur, MD at Baylor College of Medicine. The trial plans to enroll 80 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology